Wen Su

607 total citations
18 papers, 403 citations indexed

About

Wen Su is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wen Su has authored 18 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Wen Su's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Oral and Maxillofacial Pathology (3 papers). Wen Su is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Oral and Maxillofacial Pathology (3 papers). Wen Su collaborates with scholars based in China and Hong Kong. Wen Su's co-authors include Zhi‐Jun Sun, Zhigang Xu, Wei Qiu, Xianbin Ma, Jiming Xu, Hongyu Yang, Yufan Wang, Mengyun Liang, Shuo Wang and Yuejun Kang and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Journal of Ethnopharmacology.

In The Last Decade

Wen Su

18 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Su China 11 275 136 100 94 62 18 403
Sofya S. Perelman United States 6 583 2.1× 45 0.3× 40 0.4× 85 0.9× 56 0.9× 9 713
Sofía Jerez United States 11 288 1.0× 31 0.2× 174 1.7× 93 1.0× 48 0.8× 16 485
James Trevor Oswald Canada 8 266 1.0× 72 0.5× 21 0.2× 54 0.6× 40 0.6× 8 390
Can Xiao China 10 189 0.7× 76 0.6× 90 0.9× 27 0.3× 47 0.8× 28 340
Fanyi Mo United States 8 174 0.6× 185 1.4× 15 0.1× 164 1.7× 111 1.8× 11 401
Dalian He China 11 148 0.5× 42 0.3× 22 0.2× 79 0.8× 72 1.2× 22 481
E. Ashley Dozier United States 6 163 0.6× 28 0.2× 66 0.7× 201 2.1× 134 2.2× 8 453
Vinod Nadella India 12 158 0.6× 41 0.3× 25 0.3× 222 2.4× 101 1.6× 16 471

Countries citing papers authored by Wen Su

Since Specialization
Citations

This map shows the geographic impact of Wen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Su more than expected).

Fields of papers citing papers by Wen Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Su. The network helps show where Wen Su may publish in the future.

Co-authorship network of co-authors of Wen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Su. A scholar is included among the top collaborators of Wen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Su. Wen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Guan, Haixing, Linlin Zhang, Hehe Jiang, et al.. (2024). Fatty Acids Derived from Royal Jelly Exert Anti-Inflammatory and Antibacterial Activities in the Treatment of Pseudomonas aeruginosa -Induced Acute Pneumonia. Journal of Medicinal Food. 28(1). 44–57. 2 indexed citations
2.
Wang, Jing, et al.. (2024). CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine. Molecular Biology Reports. 51(1). 385–385. 3 indexed citations
3.
Liu, Jie, Wen‐Ping Lin, Wen Su, et al.. (2023). Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC. International Immunopharmacology. 119. 110243–110243. 14 indexed citations
5.
Xu, Meng-Zhen, Qinghua Cui, Wen Su, et al.. (2022). High-content screening of active components of Traditional Chinese Medicine inhibiting TGF-β-induced cell EMT. Heliyon. 8(8). e10238–e10238. 6 indexed citations
6.
Qiu, Wei, Wen Su, Jiming Xu, et al.. (2022). Immunomodulatory‐Photodynamic Nanostimulators for Invoking Pyroptosis to Augment Tumor Immunotherapy. Advanced Healthcare Materials. 11(21). e2201233–e2201233. 47 indexed citations
7.
Ma, Xianbin, Wen Su, Yuan Gao, et al.. (2022). Endogenous/exogenous stimulies inspired polyprodrug nano-inducer switches pyroptosis path for promoting antitumor immunity. Nano Today. 48. 101727–101727. 44 indexed citations
8.
Su, Wen, Wei Qiu, Shu‐Jin Li, et al.. (2022). A Dual‐Responsive STAT3 Inhibitor Nanoprodrug Combined with Oncolytic Virus Elicits Synergistic Antitumor Immune Responses by Igniting Pyroptosis. Advanced Materials. 35(11). e2209379–e2209379. 87 indexed citations
9.
Xiong, Hong‐Gang, Xianbin Ma, Xiaolong Wang, et al.. (2021). Inspired Epigenetic Modulation Synergy with Adenosine Inhibition Elicits Pyroptosis and Potentiates Cancer Immunotherapy. Advanced Functional Materials. 31(20). 58 indexed citations
10.
Su, Wen, Jun Zhao, & Ting‐Jun Fan. (2020). Dose- and Time-Dependent Cytotoxicity of Carteolol in Corneal Endothelial Cells and the Underlying Mechanisms. Frontiers in Pharmacology. 11. 202–202. 11 indexed citations
11.
Su, Wen, Jing Tang, Yufan Wang, et al.. (2019). Long non‐coding RNA highly up‐regulated in liver cancer promotes epithelial‐to‐mesenchymal transition process in oral squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 23(4). 2645–2655. 13 indexed citations
12.
Su, Wen, et al.. (2019). Circular RNA hsa_circ_0007059 indicates prognosis and influences malignant behavior via AKT/mTOR in oral squamous cell carcinoma. Journal of Cellular Physiology. 234(9). 15156–15166. 39 indexed citations
13.
Su, Wen & Hongyu Yang. (2019). [Treatment plan and prognosis of salivary adenoid cystic carcinoma with lung metastasis].. PubMed. 37(2). 214–219. 3 indexed citations
14.
Su, Wen, Yufan Wang, Feng Wang, Huijun Yang, & Hongyu Yang. (2019). [Effect of circular RNA hsa_circ_0002203 on the proliferation, migration, invasion, and apoptosis of oral squamous cell carcinoma cells].. PubMed. 37(5). 509–515. 5 indexed citations
15.
Wang, Yufan, Bowen Li, Shuai Sun, et al.. (2018). Circular RNA Expression in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 8. 398–398. 29 indexed citations
16.
Sun, Shuai, Panpan Wang, Yufan Wang, et al.. (2018). Intraductal papilloma arising from the accessory parotid gland. Medicine. 97(20). e10761–e10761. 5 indexed citations
17.
Zhao, Na, Supen Wang, Hongyi Li, et al.. (2018). Influence of Novel Highly Pathogenic Avian Influenza A (H5N1) Virus Infection on Migrating Whooper Swans Fecal Microbiota. Frontiers in Cellular and Infection Microbiology. 8. 46–46. 21 indexed citations
18.
Su, Wen, Yufan Wang, Feng Wang, Huijun Yang, & Hongyu Yang. (2018). [Effect of long non-coding RNA highly upregulated in liver cancer on the biological behavior of oral squamous cell carcinoma].. PubMed. 53(11). 760–765. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026